Subcutaneous and sublingual immunotherapy for aeroallergens improved disease severity and quality of life among patients with atopic dermatitis, according to a review published in The Journal of Allergy & Clinical Immunology.
Based on these findings, treatment for AD would benefit from shared decision-making and a multidisciplinary approach, Derek K. Chu, MD, PhD, assistant professor with the department of medicine at McMaster University, Hamilton, Ontario, Canada, and colleagues wrote.
“Allergen immunotherapy — also called specific desensitization, allergen-specific